Jeannot F. Zinsou
Lambarene, Gabon
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Predictive value of PfEMP1 antibody profiles for the course of controlled human malaria infections.
Journal: PLoS pathogens
Published: March 05, 2026
Malaria transmission dynamics, vector diversity, and insecticide resistance profiles in two health districts of southern Benin.
Journal: BMC infectious diseases
Published: March 03, 2026
Burden of group A rotavirus infection among children with acute diarrhoea in Lambaréné, Gabon.
Journal: Journal of public health in Africa
Published: August 14, 2025
Molecular-based assessment of the efficacy of anthelminthic combination regimens for the treatment of Strongyloides stercoralis in Gabon.
Journal: Parasitology research
Published: July 16, 2025
Community surveys of the prevalence, distribution, and coinfection of helminth and protozoan infections in semiurban and rural areas of Gabon, Central Africa.
Journal: PLoS neglected tropical diseases
Published: February 25, 2025
Publisher Correction: Impact of helminth infections during pregnancy on maternal and newborn Vitamin D and on birth outcomes.
Journal: Scientific reports
Published: August 22, 2024
Safety and efficacy of praziquantel in pregnant women infected with Schistosoma haematobium in Lambaréné, Gabon - Clinical results from the randomized, single-blinded, controlled freeBILy-Gabon trial.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: June 15, 2024
Focal spleen lesions in loiasis: A pilot study in Gabon.
Journal: PLoS neglected tropical diseases
Published: April 02, 2024
Impact of helminth infections during pregnancy on maternal and newborn Vitamin D and on birth outcomes.
Journal: Scientific reports
Published: February 27, 2024
Safety and immunogenicity of the co-administered Na-APR-1 and Na-GST-1 hookworm vaccines in school-aged children in Gabon: a randomised, controlled, observer-blind, phase 1, dose-escalation trial.
Journal: The Lancet. Infectious diseases
Published: January 01, 2024
Last Updated: 09/26/2026